Design and optimization of highly-selective, broad spectrum fungal CYP51 inhibitors
Year: 2017
Type: article
Institution: Viamet Pharmaceuticals (United States)
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2625315574
